View Item 

Show simple item record

Transforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapy
dc.contributor.authorElder, James T.en_US
dc.contributor.authorEllingsworth, Larry R.en_US
dc.contributor.authorFisher, Gary J.en_US
dc.contributor.authorVoorhees, John J.en_US
dc.date.accessioned2010-06-01T21:23:21Z
dc.date.available2010-06-01T21:23:21Z
dc.date.issued1990-06en_US
dc.identifier.citationELDER, JAMES T.; ELLINGSWORTH, LARRY R.; FISHER, GARY J.; VOORHEES, JOHN J. (1990). "Transforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapy." Annals of the New York Academy of Sciences 593(1 Transforming Growth Factors: Chemistry, Biology, and Therapeutics ): 218-230. <http://hdl.handle.net/2027.42/74451>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74451
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2165376&dopt=citationen_US
dc.format.extent1354742 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1990 The New York Academy of Sciencesen_US
dc.titleTransforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology University of Michigan Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherImmunology Laboratory Connective Tissue Research Laboratories Collagen Corporation Palo Alto, California 94303en_US
dc.identifier.pmid2165376en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74451/1/j.1749-6632.1990.tb16114.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1990.tb16114.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceKrueger, G. G., P. R. Bergstresser, N. Lowe, J. J. Voorhees & G. D. Weinstein. 1984. Psoriasis. J. Amer. Acad. Dermatol. 11: 937 – 947.en_US
dc.identifier.citedreferenceWeinstein, G. D. & E. J. Van Scott. 1965. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J. Invest. Dermatol. 45: 257.en_US
dc.identifier.citedreferenceBernard, B. A., D. Asselineau, L. Schaffar-Deshayes & M. Y. Darmon. 1988. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program ? J. Invest. Dermatol. 90: 801 – 805.en_US
dc.identifier.citedreferenceBraverman, I. M., & J. Sibley. 1982. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J. Invest. Dermatol. 78: 12 – 17.en_US
dc.identifier.citedreferenceBaker, B. S., A. F. Swain, H. Valdimarsson & L. Fry. 1984. T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol. 110: 37 – 44.en_US
dc.identifier.citedreferenceHammar, H., S.-Q. Gu, A. Johannesson, K.-G. Sundkvist & P. Biberfeld. 1984. Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/cytotoxic T cells in epidermis during the evolution of the lesion. J. Invest. Dermatol. 83: 416 – 420.en_US
dc.identifier.citedreferenceElder, J. T., G. J. Fisher, P. B. Lindquist, G. L. Bennett, M. R. Pittelkow, R. J. Coffey, L. Ellingsworth, R. Derynck & J. J. Voorhees. 1989. Overexpression of transforming growth factor Α in psoriatic epidermis. Science 243: 811 – 814.en_US
dc.identifier.citedreferenceGrossman, R. M., J. Krueger, D. Yourish, A. Granelli-Piperno, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal & A. B. Gottlieb. 1989. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86: 6367 – 6371.en_US
dc.identifier.citedreferenceSporn, M. B., A. B. Roberts, L. M. Wakefield & R. K. Assoian. 1986. Transforming growth factor-Β: Biological function and chemical structure. Science 233: 532 – 534.en_US
dc.identifier.citedreferenceKeski-Oja, J. & H. L. Moses. 1987. Growth inhibitory polypeptides in the regulation of cell proliferation. Med. Biol. 65: 13 – 20.en_US
dc.identifier.citedreferenceShipley, G. D., M. R. Pittelkow, J. J. Wille, R. E. Scott & H. L. Moses. 1986. Reversible inhibition of normal human prokeratinocyte proliferation by type Β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46: 2068 – 2071.en_US
dc.identifier.citedreferenceWilke, M. S., B. M. Hsu, J. J. Wille, M. R. Pittelkow & R. E. Scott. 1988. Biologic mechanisms for the regulation of normal human keratinocyte proliferation and differentiation. Am. J. Pathol. 131: 171 – 181.en_US
dc.identifier.citedreferenceEllingworth, L. R., J. E. Brennan, K. Fok, D. M. Rosen, H. Bentz, K. A. Piez & S. M. Seyedin. 1986. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor Β. J. Biol. Chem. 261: 12362 – 12367.en_US
dc.identifier.citedreferenceFrolik, C., L. Wakefield, D. Smith & M. Sporn. 1984. Characterization of a membrane receptor for transforming growth factor-Β in normal rat kidney fibroblasts. J. Biol. Chem. 259: 10995 – 11000.en_US
dc.identifier.citedreferenceWille, J. J., M. R. Pittelkow, G. R. Shipley & R. E. Scott. 1984. Integrated Control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J. Cell. Physiol. 121: 31 – 44.en_US
dc.identifier.citedreferenceBoyce, S. T. & R. G. Ham. Normal human epidermal keratinocytes. In In Vitro Models for Cancer Research. Vol. III. M. M. Webber & L. I. Sekely, Eds.: 245 – 274. CRC Press. Boca Raton, FL.en_US
dc.identifier.citedreferenceNickoloff, B. J., R. S. Mitra, J. T. Elder, G. J. Fisher & J. J. Voorhees. 1989. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-Α production in keratinocytes cultured from psoriatic lesions. Br. J. Dermatol. 121: 1 – 14.en_US
dc.identifier.citedreferenceElder, J. T., A. K. Gupta, G. J. Fisher & J. J. Voorhees. 1988. Cyclosporine inhibits ornithine decarboxylase gene expression and acute inflammation in response to phorbol ester treatment of hairless mouse skin. Transplant Proc. 20: 95 – 104.en_US
dc.identifier.citedreferenceDerynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton & J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn & D. V. Goeddel. 1985. Human transforming growth factor-Β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701 – 705.en_US
dc.identifier.citedreferenceGinsburg, D., R. Zeheb, A. Y. Yang, U. M. Rafferty, P. A. Andreasen, L. Nielsen, K. Dano, R. V. Lebo & T. D. Gelehrter. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 78: 1673 – 1680.en_US
dc.identifier.citedreferenceEllingsworth, L. R., D. Nakayama, P. Segarini, J. Dasch, P. Carrillo & W. Waegell. Transforming growth factor-Βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. Cell. Immun. 114: 41 – 54.en_US
dc.identifier.citedreferenceKimchi, A., X.-F. Wang, R. A. Weinberg, S. Cheifetz & J. MassaguÉ. 1988. Absence of TGF-Β receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196 – 199.en_US
dc.identifier.citedreferenceSchwartz, P. M., L. C. Kugelman, Y. Coifman, L. M. Hough & L. M. Milstone. 1988. Human keratinocytes catabolize thymidine. J. Invest. Dermatol. 90: 8 – 12.en_US
dc.identifier.citedreferenceKane, C. J. M., P. C. Hanawalt, A. M. Knapp & J. N. Mansbridge. 1989. Immunohistochemical localization of transforming growth factor-Β protein in psoriasis. J. Invest. Dermatol. 92A: 455.en_US
dc.identifier.citedreferenceWakefield, L. M., D. M. Smith, K. C. Flanders & M. B. Sporn. 1988. Latent transforming growth factor-Β from human platelets. J. Biol. Chem. 263: 7646 – 7654.en_US
dc.identifier.citedreferenceMassague, J. 1987. The TGF-Β family of growth and differentiation factors. Cell 49: 437 – 438.en_US
dc.identifier.citedreferenceDerynck, R., P. B. Lindquist, A. Lee, D. Wen, J. Tamm, J. L. Graycar, L. Rhee, A. J. Mason, D. A. Miller, R. J. Coffey, H. L. Moses & E. Y. Chen. 1988. A new type of transforming growth factor-Β, TGF-Β. EMBO J. 7: 3737 – 3743.en_US
dc.identifier.citedreferenceJakowlew, S. B., P. J. Dillard, M. B. Sporn & A. B. Roberts. 1988. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor Β4 from chicken embryo chondrocytes. Mol. Endo. 2: 1186 – 1195.en_US
dc.identifier.citedreferenceCoffey, R. J., C. C. Bascom, N. J. Spies, R. Graves-Deal, B. E. Weissman & H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor Β. Mol. Cell Biol. 8: 3088 – 3093.en_US
dc.identifier.citedreferenceHelseth, E., A. Dalen, G. Unsgaard, T. Skandsen, J. Grondahl-Hansen & L. R. Lund. 1988. Transforming growth factor-Β1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines. Acta Pathol. Microbiol. Immunol. Scand. 96: 845 – 849.en_US
dc.identifier.citedreferenceKeski-Oja, J., R. Raghow, M. Sawdey, D. J. Loskutoff, A. E. Postlethwaite, A. H. Kang & H. L. Moses. 1988. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-Β. J. Biol. Chem. 263: 3111 – 3115.en_US
dc.identifier.citedreferenceWilke, M. S., B. M. Hsu & R. E. Scott. 1988. Two subtypes of reversible cell cycle restriction points exist in cultured normal human kertinocyte progenitor cells. Lab. Invest. 58: 660 – 666.en_US
dc.identifier.citedreferenceElder, J. T., A. Tavakkol, S. B. Klein, M. E. Zeigler, M. Wicha & J. J. Voorhees. 1990. Protooncogene expression in normal and psoriatic skin. J. Invest. Dermatol. 94: 19 – 25.en_US
dc.identifier.citedreferenceBoyd, F. T. & J. Massague. 1989. Transforming growth factor-Β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem. 264: 2272 – 2278.en_US
dc.identifier.citedreferenceMustoe, T. A., G. F. Pierce, A. Thomason, P. Gramaies, M. B. Sporn & T. F. Deuel. 1987. Accelerated healing of incisional wounds in rats induced by transforming growth factor-Β. Science 237: 1333 – 1336.en_US
dc.identifier.citedreferenceCoffey, R. J., L. J. Kost, R. M. Lyons, H. L. Moses & N. F. LaRusso. 1987. Hepatic processing of transforming growth factor Β in the rat. J. Clin. Invest. 80: 750 – 757.en_US
dc.identifier.citedreferenceFisher, G. J., E. A. Duell, B. J. Nickoloff, T. M. Annesley, J. K. Kowalke, C. N. Ellis & J. J. Voorhees. 1988. Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J. Invest. Dermatol. 91: 142 – 146.en_US
dc.identifier.citedreferenceWahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney-Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts & M. B. Sporn. Transforming growth factor-Β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140: 3026 – 3032.en_US
dc.identifier.citedreferenceKehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn & A. S. Fauci. 1986. Production of transforming growth factor Β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037 – 1050.en_US
dc.identifier.citedreferenceNickoloff, B. J. & R. S. Mitra. 1988. Transforming growth factor-beta is a keratinocyte-derived lymphocyte inhibitory factor. J. Invest. Dermatol. 90A: 592.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1749-6632.1990.tb16114.x.pdf
Size:
1.291MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.